Interestingly, plasma Gal1 levels detected by ELISA are found to be significantly increased in patients with PDA as compared to a control group, underscoring the potential of using circulating Gal1 levels as a diagnosis biomarker [59]. Here, LGALS1 is linked to Patent ductus arteriosus.